LONDON, Nov 15 (Reuters) - Global health advocates have written to the makers of a key mpox diagnostic test to call for its price to be cut from around $20 per test to $5, to help tackle low testing ...

For much of last year, the coronavirus crept, undetected, across eastern Democratic Republic of Congo. Test samples had to be sent more than 1,500 kilometres from remote hospitals to the capital ...

Cepheid's performance in the first quarter was driven by robust growth in clinical product sales resulting from test utilization in the emerging HAI test market for Xpert MRSA, continued adoption of ...

First and Only Trichomonas NAAT Test with Male Urine Claims Cleared for Use in United States Following initial clearance of Xpert TV for three types of female specimens in October of 2015, the latest ...

BUFFALO, N.Y. — It appears testing supplies that would have bolstered Erie County's ability to test for COVID-19 are being diverted to coronavirus hot spots first. A spokeswoman for California-based ...

Testing for COVID-19 is technical, expensive and complicated -- particularly in Alaska, with its remote, far-flung communities and overlapping systems of tribal and private health care. That ...

(MENAFN- EIN Presswire) EINPresswire/ -- The Pneumonia Testing Market: A thorough analysis of statistics about the current as well as emerging trends offers clarity regarding the Pneumonia Testing ...

Danaher Corp. DHR announced its first major acquisition since it spun off a large chunk of its business. The company has inked a definitive agreement to buy molecular diagnostics company Cepheid CPHD ...

NEW YORK (AP) -- Shares of molecular diagnostics company Cepheid rose Friday after the company said it received marketing approval for a test for chlamydia and gonorrhea. THE SPARK: Cepheid said the ...

Cepheid Inc. first made its name with anthrax-detection tests to guard the nation's post offices from bioterrorism attacks back in 2001. Now, the Sunnyvale company's gene-based testing system is ...

The Cepheid manufacturing project in India was initiated in 2018 to support the dynamic India market. (FE.com) Cepheid, a key player in molecular diagnostics company, on Tuesday, announced the launch ...

The U.S. Food and Drug Administration has approved the first rapid coronavirus diagnostic test, with a detection time of about 45 minutes, the test’s developer, Sunnyvale-based molecular diagnostics ...